Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia
Emma L. Boys(The University of Sydney), Jia Liu(The University of Sydney), Karen L. MacKenzie(The University of Sydney), Roger R. Reddel(Children's Medical Research Institute), Bo Gao(Blacktown & Mount Druitt Hospital), Sarah Sutherland(The University of Sydney), Peter Grimison(The University of Sydney)
Cited by 8
Related Papers
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
|Journal of Thoracic Oncology|2019|437
Machine learning for multi-omics data integration in cancer
|iScience|2022|298
Five dysfunctional telomeres predict onset of senescence in human cells
|EMBO Reports|2011|220
Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.
|Journal of Clinical Oncology|2018|208
ATRX represses alternative lengthening of telomeres
|Oncotarget|2015|174